Navigation Links
The fatality rate among hard drug users is 14 times higher than for the general population
Date:2/7/2014

between 1997 and 2007; they were aged between 15 and 49 years at the time of being recruited and were cross-referenced with the general mortality register for the 1997-2008 period, in order to observe their vital condition.

Excess mortality adjusted death rate ratio between participants and the general population was considerable in both groups of participants. In fact, the death rate among those who also consumed heroin was 14.3 times higher than for the general population, while among those who did not consume this substance, it was 5.1 times higher.

The results also revealed that was a greater chance of men dying than women among those who also consumed heroin (1.5 times), while no differences were found according to sex among those who did not consume this substance.

The authors stated that the excess mortality found is within the range of the results published in the past in other countries (4-12 times higher).

Other related factors

Apart from the use of heroine, other factors related to the greater risk of death were identified, such as the absence of regular employment, drug use by injection or consuming cocaine on a daily basis.

"This excess mortality may be due to the consumption of cocaine or heroin, but there are also other factors that may be different among the general population and the participants, such as mental disorders, personality traits, social conditions, etc.," said Barrio.

Another interesting finding was that the excess mortality with regard to the general population of the same age and sex was significantly higher among women than among men, particularly among those who consumed cocaine but not heroin (8.6 times in women compared with 3.5 times in men).

"This information does not mean that female cocaine consumers have a significantly greater risk of death than their male counterparts, but that the relative increased risk of female cocaine consu
'/>"/>

Contact: Sinc Agency
info@agenciasinc.es
34-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Why is traumatic brain injury increasing among the elderly?
2. Overuse Injuries Common Among Female College Athletes
3. Predictors identified for rehospitalization among post-acute stroke patients
4. Job injuries among youth prompt calls for better safety standards
5. Death From Accidental Injuries Among Kids Drops 30%: CDC
6. Swallowing exercises linked with short-term improvement among patients with head and neck cancer
7. Study examines drug regimen for the treatment of non-small cell lung cancer among older patients
8. Study examines adverse effects among different radiation therapies for prostate cancer
9. Killing in war linked with suicidal thoughts among Vietnam veterans, study finds
10. Moffitt researchers find cancer therapies affect cognitive functioning among breast cancer survivors
11. Mayo Clinic: Obesity epidemic fueling rise in rheumatoid arthritis among women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... ... Purdy as the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen ... in companies ranging from a multi-billion dollar, global chemical company to early and ...
(Date:7/7/2015)... ... 2015 , ... RadSite™, a leading accreditation agency for diagnostic ... Medicare and Medicaid Services (CMS), announces that it has updated its website for ... most effective websites are those that provide timely information, frequent updates and a ...
(Date:7/7/2015)... ... 07, 2015 , ... On May 29, 2015, Health Canada announced that they ... gluten-free claims for gluten free oats and foods that contain them as ingredients. , ... (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, VP of ...
(Date:7/7/2015)... ... 2015 , ... CareSync proudly announces today that Amy Gleason, ... House as a “Champion of Change” for Precision Medicine on Wednesday, July 8th. ... Change program recognizes Gleason and eight other extraordinary individuals who are making great ...
(Date:7/6/2015)... ... July 06, 2015 , ... For over twenty years, Doctors on Liens ... Throughout the company’s history the goal has been to be a comprehensive network ... recovery. And while Doctors on Liens has certainly achieved that goal, the addition ...
Breaking Medicine News(10 mins):Health News:Office Practicum Announces new CFO 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3
... ... month of February, sports’ betting was the third most frequently cited primary problem experienced ... Super Bowl and the Kentucky Derby have a substantial effect on sports bettors in ... , ...
... ... ... a workforce solutions company placing health care professionals in contract assignments at hospitals ... Janet S. Elkin as President and Chief Executive Officer of the Park City, Utah ...
... ... in Hospital Medicine designation. , ... (PRWEB) March 12, 2010 -- The Society of Hospital Medicine (SHM) has announced that Dr. ... who have earned the first-ever Senior Fellow in Hospital Medicine (SFHM) designation. Along with other ...
... ... , ... ... NEW YORK , March 12 In releasing a new report on maternal health nationwide, Amnesty ...
... ... , ... ... NEW YORK , March 12 In releasing a new report on maternal health nationwide, Amnesty International today revealed that ...
... of Women Live in a Medically Underserved Area , ... , , ... ... NEW YORK , March 12 ...
Cached Medicine News:Health News:It's March Madness and the Florida Council on Compulsive Gambling Reminds Fans they don't have to Wager to Enjoy the Game 2Health News:Supplemental Health Care Names New Leader 2Health News:Supplemental Health Care Names New Leader 3Health News:Senior Fellow in Hospital Medicine 2Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; California 35th Among All States in Maternal Mortality 2Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; California 35th Among All States in Maternal Mortality 3Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; California 35th Among All States in Maternal Mortality 4Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; California 35th Among All States in Maternal Mortality 5Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; California 35th Among All States in Maternal Mortality 6Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; California 35th Among All States in Maternal Mortality 7Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality 2Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality 3Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality 4Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality 5Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality 6Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality 7Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality 2Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality 3Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality 4Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality 5Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality 6Health News:New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality 7
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... SOUTH SAN FRANCISCO, Calif. , July 6, 2015 ... leading global pharmaceutical company, and Oculeve, a development-stage medical ... eye disease, today announced that they have entered into ... an all-cash transaction.  Under the terms of the agreement, ... payment and commercialization milestone payments related to Oculeve,s lead ...
(Date:7/6/2015)... SHENZHEN, China , July 6, 2015 China ... CNIT), a leading provider of integrated cloud-based platform, exchange, ... , today announced that the Company launched its mobile ... age of accessible healthcare services on mobile devices. The ... District Health and Family Planning Bureau and Shenzhen News ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... 8 Cell Therapeutics, Inc. (CTI),(Nasdaq and ... data for the,Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line Indolent ... Hematology (ASH) 50th Annual Meeting by,Morschhauser, et ... (PFS) following Zevalin consolidation therapy for patients ...
... Patients with non-valvular,atrial fibrillation receiving either 30 mg ... oral Factor Xa inhibitor, experienced comparable,safety and tolerability ... II data presented today at the 50th Annual ... Francisco. These findings are the first results,from ...
Cached Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 2New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 3New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 4New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 5
... white LED (Light Emitting Diode) light source, coupled ... the freedom of using a slit lamp anywhere ... about 1.5 lbs. (0.68 kg) with its battery ... Its ergonomic, portable design and convenient carrying ...
Powerful LED Illumination , The ultrabright and compact 3S LED HeadLight from HEINE for Powerful, coaxial illumination...
... Abnormal Control Serum is intended for monitoring the ... assays. It is for in vitro diagnostic use ... format, the control offers up to ten days ... control is to be used in accordance with ...
e-MDs Bill practice management system is used in the medical billing cycle....
Medicine Products: